阅读说明：本技术 源自血液的谷氨酸-纤溶酶原的制备和使用 (Preparation and use of glutamic acid-plasminogen from blood ) 是由 R·格鲁伯 H·R·格尔丁 M·马楚尔 S·T·基西希 H·E·卡热斯 于 2018-03-09 设计创作，主要内容包括：本发明涉及一种分离Glu-纤溶酶原的方法,所述方法对包括血浆或包含Glu-纤溶酶原的血浆级分进行阴离子色谱交换。此外,本发明还涉及用本发明的方法获得的Glu-纤溶酶原及其在治疗方面的用途。所述治疗用途是针对患有或有风险患有以下疾病的患者：器官衰竭,血栓形成事件,动脉阻塞性疾病,微循环,弥散性血管内凝血(DIC)及其中两种或更多种的组合。(The present invention relates to a method for isolating Glu-plasminogen by anion chromatographic exchange of a plasma fraction comprising or comprising Glu-plasminogen. Furthermore, the invention relates to Glu-plasminogen obtained with the method of the invention and to its use in therapy. The therapeutic use is for a patient suffering from or at risk of suffering from: organ failure, thrombotic events, arterial occlusive disease, microcirculation, Disseminated Intravascular Coagulation (DIC), and combinations of two or more thereof.)